Literature DB >> 19740311

The hinge region fragment of immunoglobulin G improves immunogenicity of recombinant gonadotrophin-releasing hormone conjugated to the T-helper epitope in designing peptide vaccines.

Jinshu Xu1, Jie Wu, Xuejun Wang, Yin Zhang, Wenjia Li, Zheng Zhu, Dongya Zhu, Zhuoyi Hu, Rouel S Roque, Jingjing Liu.   

Abstract

In our previous study, the hinge fragment (225-232/225'-232') of human immunoglobulin G1 (IgG1) was used as a space peptide linker for synthesizing the GnRH3-hinge-MVP chimeric peptide, whereby three repeated gonadotrophin-releasing hormone (GnRH) units and a T-cell epitope from measles virus fusion protein (MVP) were amide-bond-linked at the N and C terminus, respectively, to the hinge peptide for producing anti-GnRH antibody responses. To investigate whether or not the hinge region fragment can improve the immunogenicity of GnRH, we further synthesized and purified GnRH3-hinge-MVP, GnRH3-hinge and GnRH3-MVP using recombinant DNA technology. Under high pH conditions, GnRH3-hinge-MVP was capable of forming double-chain structures. Immunization of male mice with the immunogens of GnRH3-hinge-MVP resulted in the generation of high-titre antibodies specific for GnRH. The synthetic GnRH3-hinge and GnRH3-MVP induced a lower titre of anti-GnRH antibody than GnRH3-hinge-MVP. This was followed by a decrease in serum testosterone levels, which resulted in a low level of expression of the relaxin-like factor gene in the testis. Our data suggest that peptide and T-cell epitopes oriented at the N-terminus or C-terminus of hinge peptides simplify the antigenic peptide conjugates and may be considered as potential synthetic immunogens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19740311      PMCID: PMC2753910          DOI: 10.1111/j.1365-2567.2008.03020.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Carrier-priming leads to hapten-specific suppression.

Authors:  L A Herzenberg; T Tokuhisa; L A Herzenberg
Journal:  Nature       Date:  1980-06-26       Impact factor: 49.962

2.  Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.0 A resolution.

Authors:  M Marquart; J Deisenhofer; R Huber; W Palm
Journal:  J Mol Biol       Date:  1980-08-25       Impact factor: 5.469

3.  Influence of carrier protein conjugation site and terminal modification of a GnRH-I peptide sequence in the development of a highly specific anti-fertility vaccine. Part I.

Authors:  Valerie A Ferro; Mohammad A H Khan; Elizabeth R Earl; Michael J A Harvey; Angela Colston; William H Stimson
Journal:  Am J Reprod Immunol       Date:  2002-12       Impact factor: 3.886

4.  Changes in the reproductive system of male mice immunized with a GnRH-analogue conjugated to mycobacterial hsp70.

Authors:  S G Hannesdóttir; X Han; T Lund; M Singh; R Van Der Zee; I M Roitt; P J Delves
Journal:  Reproduction       Date:  2004-09       Impact factor: 3.906

5.  The immunogenicity of recombinant and dimeric gonadotrophin-releasing hormone vaccines incorporating a T-helper epitope and GnRH or repeated GnRH units.

Authors:  Xu Jinshu; Liu Jingjing; Peng Duan; Zhu Zheng; Ming Ding; Wu Jie; Cao Rongyue; Hu Zhuoyi
Journal:  J Immunol Methods       Date:  2004-06       Impact factor: 2.303

6.  A recombinant luteinising-hormone-releasing-hormone immunogen bioeffective in causing prostatic atrophy.

Authors:  G P Talwar; Komal Raina; Jagdish C Gupta; Ruma Ray; S Wadhwa; Mushir M Ali
Journal:  Vaccine       Date:  2004-09-09       Impact factor: 3.641

7.  Immunization with a recombinant GnRH vaccine conjugated to heat shock protein 65 inhibits tumor growth in orthotopic prostate cancer mouse model.

Authors:  Jinshu Xu; Zheng Zhu; Jie Wu; Wentao Liu; Xiangchun Shen; Yin Zhang; Zhuoyi Hu; Dongya Zhu; Rouel S Roque; Jingjing Liu
Journal:  Cancer Lett       Date:  2007-11-26       Impact factor: 8.679

8.  Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.

Authors:  Weiguang Zeng; Souravi Ghosh; Yuk Fai Lau; Lorena E Brown; David C Jackson
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

9.  Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.

Authors:  Ivette Caro-Aguilar; Alexandra Rodríguez; J Mauricio Calvo-Calle; Fanny Guzmán; Patricia De la Vega; Manuel Elkin Patarroyo; Mary R Galinski; Alberto Moreno
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

10.  Vaccination against gonadotropin-releasing hormone (GnRH) using toxin receptor-binding domain-conjugated GnRH repeats.

Authors:  C T Hsu; C Y Ting; C J Ting; T Y Chen; C P Lin; J Whang-Peng; J Hwang
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.